Oncodea Corp. is a for-profit biotechnology company headquartered in Saint Paul, Minnesota, that has received support from local programs like Launch MN.
Subscribe to see Oncodea Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Oncodea Corp is a consumer app company headquartered in Saint Paul, United States. Its most recent funding round raised $275,818 in April 2022. Xcout tracks 9 named people at Oncodea Corp, including Randy Schiestl (Chief Operating Officer).
As of 16 November 2026. Source: Xcout Intel.
3 more named people on record for Oncodea Corp, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $275,818 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Oncodea Corp's closest competitors — see the full list of competitors and alternatives →
Cytotheryx is a biotechnology company based in Rochester, Minnesota, developing a platform technology to increase the supply of liver cells for pharmaceutical use.
Launch Therapeutics provides biotech and biopharma companies with solutions that accelerate drug candidates' path to market and investor connections. The company maintains primary offices in Boston, Massachusetts and Raleigh, North Carolina.
OncoResponse, Inc. is a clinical-stage biotechnology company leveraging a human antibody discovery platform to develop cancer immunotherapies. The company maintains corporate office operations in Houston, Texas and Seattle, Washington.
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Gila Therapeutics, Inc. is a biotechnology startup founded in April 2014 and located in Minneapolis, Minnesota. The company operates in the US healthcare and life sciences sector.
Ona Therapeutics is a biotechnology company founded in 2019 and headquartered in Barcelona, Spain, specializing in the design of first-in-class biotherapeutics and ADCs to attack advanced cancer.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Oncodea Corp? Suggest a correction · Work at Oncodea Corp? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.